Literature DB >> 17089136

Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.

Shigeto Ohta1, Kazuhiko Hanashiro, Masanori Sunagawa, Tetsuya Tono, Mikio Suzuki, Tadayoshi Kosugi.   

Abstract

The aim of our study was to investigate a possible correlation between Epstein-Barr virus (EBV) infection status, including its latent gene expression, and expression of allergy-related genes in human tonsil-derived cells. In the tonsil-derived cells from the patients undergoing routine tonsillectomies for palatine tonsil hypertrophy or tonsillar focal infection, the presence of EBV DNA and mRNA expressions of latent membrane protein (LMP)-1, C epsilon chain, and activation-induced cytidine deaminase (AID) were detected by PCR and RT-PCR analysis, respectively. Of all the 12 patients, PCR products amplified from EBV DNA BamHI W fragment were detected in the tonsils from the 10 patients (83.3%). LMP1 mRNA expressions were confirmed in the six patients (50%). Both LMP1 mRNA expressions and EBV DNA were detected in the five patients. EBV DNA, but not LMP1 mRNA expression, was detected in the five patients. LMP1 mRNA expression, but not EBV DNA, was detected in one patient. In one patient, neither EBV DNA nor LMP1 mRNA expression was confirmed. C epsilon mRNA expressions were confirmed in all the 12 patients along with AID mRNA expressions. The degree of C epsilon mRNA expression, however, varied with the patients. The Fisher's exact probability test revealed a statistically significant correlation between LMP1 and C epsilon gene expressions, indicating that C epsilon mRNA expression level was significantly higher in the LMP1 positive samples than in the negative samples. On the other hand, there was no significant correlation between AID and LMP1 mRNA expressions. Thus, EBV infection is a notable factor capable of exacerbating allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089136     DOI: 10.1007/s00405-006-0191-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

Review 1.  Concepts of the pathogenesis of allergic disease: possible roles of Epstein-Barr virus infection and interleukin-2 production.

Authors:  H Okudaira; A Mori
Journal:  Int Arch Allergy Immunol       Date:  1999-11       Impact factor: 2.749

2.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

Review 3.  Epstein-Barr virus latent membrane protein 1: structure and functions.

Authors:  Hsin-Pai Li; Yu-Sun Chang
Journal:  J Biomed Sci       Date:  2003 Sep-Oct       Impact factor: 8.410

4.  Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease.

Authors:  M Calvani; C Alessandri; G Paolone; L Rosengard; A Di Caro; D De Franco
Journal:  Pediatr Allergy Immunol       Date:  1997-05       Impact factor: 6.377

5.  Increased serum levels of antibodies to Epstein-Barr virus in adults with history of atopic dermatitis.

Authors:  I Rystedt; I L Strannegård; O Strannegård
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

6.  Enumeration of IgE secreting B cells. A filter spot-ELISA.

Authors:  C L King; G Thyphronitis; T B Nutman
Journal:  J Immunol Methods       Date:  1990-08-28       Impact factor: 2.303

7.  Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Authors:  J Uchida; T Yasui; Y Takaoka-Shichijo; M Muraoka; W Kulwichit; N Raab-Traub; H Kikutani
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

8.  Viral infections associated with recurrent tonsillitis.

Authors:  N Yamanaka; A Kataura
Journal:  Acta Otolaryngol Suppl       Date:  1984

9.  Epstein-Barr virus antibodies in children with atopic disease.

Authors:  I L Strannegård; O Strannegård
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

Review 10.  The immune response to Epstein-Barr virus.

Authors:  Margaret F C Callan
Journal:  Microbes Infect       Date:  2004-08       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.